Advanced search
Publication Cover
Molecular and Cellular Biology Volume 22, 2002 - Issue 4
Submit an article Journal homepage
130
Views
228
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Receptor Activator of NF-κB Ligand (RANKL) Activates TAK1 Mitogen-Activated Protein Kinase Kinase Kinase through a Signaling Complex Containing RANK, TAB2, and TRAF6

Junko Mizukami1 Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd., Yodogawa-ku, Osaka532-8505
,
Giichi Takaesu2 Department of Molecular Biology, Graduate School of Science, Nagoya University, and CREST, Japan Science and Technology Corporation, Chikusa-ku, Nagoya464-8602, Japan
,
Hiroyuki Akatsuka1 Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd., Yodogawa-ku, Osaka532-8505
,
Hiroaki Sakurai1 Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd., Yodogawa-ku, Osaka532-8505
,
Jun Ninomiya-Tsuji2 Department of Molecular Biology, Graduate School of Science, Nagoya University, and CREST, Japan Science and Technology Corporation, Chikusa-ku, Nagoya464-8602, Japan
,
Kunihiro Matsumoto2 Department of Molecular Biology, Graduate School of Science, Nagoya University, and CREST, Japan Science and Technology Corporation, Chikusa-ku, Nagoya464-8602, Japan
&
Naoki Sakurai1 Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd., Yodogawa-ku, Osaka532-8505Correspondence[email protected]
 show all
Pages 992-1000 | Received 16 Jul 2001, Accepted 20 Nov 2001, Published online: 28 Mar 2023

Citations (228)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Soomin Lim, Hye Jung Ihn, Ju Ang Kim, Jong-Sup Bae, Jung-Eun Kim, Yong Chul Bae, Hong-In Shin, Tae Hoon Kim & Eui Kyun Park. (2023) Suppressive effects of (-)-tubaic acid on RANKL-induced osteoclast differentiation and bone resorption. Animal Cells and Systems 27:1, pages 1-9.
Read now
Xuedong Li, Xixi Lin, Zuoxing Wu, Yuangang Su, Jiamin Liang, Runfeng Chen, Xue Yang, Lei Hou, Jinmin Zhao, Qian Liu & Feng Xu. (2021) Pristimerin Protects Against OVX-Mediated Bone Loss by Attenuating Osteoclast Formation and Activity via Inhibition of RANKL-Mediated Activation of NF-κB and ERK Signaling Pathways. Drug Design, Development and Therapy 15, pages 61-74.
Read now
Jiaxuan Peng, Kangxian Zhao, Jiling Zhu, Yanben Wang, Peng Sun, Qichang Yang, Tan Zhang, Weiqi Han, Wenjun Hu, Wanlei Yang, Jianwei Ruan & Yu Qian. (2020) Sarsasapogenin Suppresses RANKL-Induced Osteoclastogenesis in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo. Drug Design, Development and Therapy 14, pages 3435-3447.
Read now
Heiani Touaitahuata, Anne Blangy & Virginie Vives. (2014) Modulation of osteoclast differentiation and bone resorption by Rho GTPases. Small GTPases 5:1.
Read now
Betty Lamothe, YunJu Lai, Min Xie, Michael D. Schneider & Bryant G. Darnay. (2013) TAK1 Is Essential for Osteoclast Differentiation and Is an Important Modulator of Cell Death by Apoptosis and Necroptosis. Molecular and Cellular Biology 33:3, pages 582-595.
Read now
Joel Jules, Jason W Ashley & Xu Feng. (2010) Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis. Expert Opinion on Therapeutic Targets 14:9, pages 923-934.
Read now
AKINORI HISHIYA, KYOJI IKEDA & KEN WATANABE. (2005) A RANKL-Inducible Gene in Osteoclast Differentiation. Journal of Receptors and Signal Transduction 25:3, pages 199-216.
Read now

Articles from other publishers (221)

Aleena Anwar, Leena Sapra, Navita Gupta, Rudra P. Ojha, Bhupendra Verma & Rupesh K. Srivastava. (2023) Fine‐tuning osteoclastogenesis: An insight into the cellular and molecular regulation of osteoclastogenesis. Journal of Cellular Physiology 238:7, pages 1431-1464.
Crossref
Masataka Anzai, Miho Watanabe-Takahashi, Hiroshi Kawabata, Saori Mizuno, Yuu Taguchi, Jun-ichiro Inoue & Kiyotaka Nishikawa. (2022) A tetravalent peptide that binds to the RANK-binding region of TRAF6 via a multivalent interaction efficiently inhibits osteoclast differentiation. Biochemical and Biophysical Research Communications 636, pages 178-183.
Crossref
Bing Yang, Xi Yang, Xumei Tan, Liqing Lu, Wei Fan, Lucía Barbier-Torres, Justin Steggerda, Ting Liu & Heping Yang. (2022) Regulatory Networks, Management Approaches, and Emerging Treatments of Nonalcoholic Fatty Liver Disease. Canadian Journal of Gastroenterology and Hepatology 2022, pages 1-18.
Crossref
Meng-Huang Wu, Wei-Bin Hsu, Mei-Hsin Chen & Chung-Sheng Shi. (2022) Inhibition of Neddylation Suppresses Osteoclast Differentiation and Function In Vitro and Alleviates Osteoporosis In Vivo. Biomedicines 10:10, pages 2355.
Crossref
Wei Deng, YanBo Huang, HaiShang Li, ChiWei Chen, YueWei Lin, Min Wang, HuaSheng Huang, Teng Liu, QiuLi Qin, Yang Shao, YongChao Tang, Kai Yuan, JinYong Ding, LiangLiang Xu, YongXian Li & ShunCong Zhang. (2022) Dehydromiltirone inhibits osteoclast differentiation in RAW264.7 and bone marrow macrophages by modulating MAPK and NF-κB activity. Frontiers in Pharmacology 13.
Crossref
Lin-Yu Jin, Shi-Cheng Huo, Chen Guo, Hai-Ying Liu, Shuai Xu & Xin-Feng Li. (2022) GSK 650394 Inhibits Osteoclasts Differentiation and Prevents Bone Loss via Promoting the Activities of Antioxidant Enzymes In Vitro and In Vivo. Oxidative Medicine and Cellular Longevity 2022, pages 1-20.
Crossref
Wu Jianwei, Tian Ye, Wang Hongwei, Li Dachuan, Zou Fei, Jiang Jianyuan & Wang Hongli. (2022) The Role of TAK1 in RANKL-Induced Osteoclastogenesis. Calcified Tissue International 111:1, pages 1-12.
Crossref
Xin Fu, Xiaochen Sun, Chenxi Zhang, Nanning Lv, Huan Guo, Chunlei Xing, Juan Lv, Jiwen Wu, Xiaoli Zhu, Mingming Liu & Li Su. (2022) Genkwanin Prevents Lipopolysaccharide-Induced Inflammatory Bone Destruction and Ovariectomy-Induced Bone Loss. Frontiers in Nutrition 9.
Crossref
Sharon Russo, Federica Scotto di Carlo & Fernando Gianfrancesco. (2022) The Osteoclast Traces the Route to Bone Tumors and Metastases. Frontiers in Cell and Developmental Biology 10.
Crossref
Nur Hanisah Mustafa, Mahendran Sekar, Shivkanya Fuloria, M. Yasmin Begum, Siew Hua Gan, Nur Najihah Izzati Mat Rani, Subban Ravi, Kumarappan Chidambaram, Vetriselvan Subramaniyan, Kathiresan V. Sathasivam, Srikanth Jeyabalan, Subasini Uthirapathy, Sivasankaran Ponnusankar, Pei Teng Lum, Vijay Bhalla & Neeraj Kumar Fuloria. (2022) Chemistry, Biosynthesis and Pharmacology of Sarsasapogenin: A Potential Natural Steroid Molecule for New Drug Design, Development and Therapy. Molecules 27:6, pages 2032.
Crossref
Kanokkarn Phromnoi, Supachai Yodkeeree, Komsak Pintha, Sariya Mapoung, Maitree Suttajit, Chalermpong Saenjum & Pornngarm Dejkriengkraikul. (2022) Anti-Osteoporosis Effect of Perilla frutescens Leaf Hexane Fraction through Regulating Osteoclast and Osteoblast Differentiation. Molecules 27:3, pages 824.
Crossref
Sunhee Jang, Eui-Jong Kwon & Jennifer Jooha Lee. (2022) Rheumatoid Arthritis: Pathogenic Roles of Diverse Immune Cells. International Journal of Molecular Sciences 23:2, pages 905.
Crossref
Shuai Feng, Ting Wang, Liming Fan, Xinxin An, Xinli Ding, Minjuan Wang, Xifeng Zhai, Yanjun Cao, Jiao He & Yang Li. (2022) Exploring the potential therapeutic effect of Eucommia ulmoides – Dipsaci Radix herbal pair on osteoporosis based on network pharmacology and molecular docking technology . RSC Advances 12:4, pages 2181-2195.
Crossref
Sungyub Lee, Minsun Kim, Sooyeon Hong, Eom Ji Kim, Jae-Hyun Kim, Youngjoo Sohn & Hyuk-Sang Jung. (2022) Effects of Sparganii Rhizoma on Osteoclast Formation and Osteoblast Differentiation and on an OVX-Induced Bone Loss Model. Frontiers in Pharmacology 12.
Crossref
Silvia Marino, Nicole Hannemann, Ryan T. Bishop, Feier Zeng, Giovana Carrasco, Sandrine Meurisse, Boya Li, Antonia Sophocleous, Anna Sparatore, Tobias Baeuerle, Slobodan Vukicevic, Marielle Auberval, Patrick Mollat, Aline Bozec & Aymen I. Idris. (2022) Anti-inflammatory, but not osteoprotective, effect of the TRAF6/CD40 inhibitor 6877002 in rodent models of local and systemic osteolysis. Biochemical Pharmacology 195, pages 114869.
Crossref
Rohan Gupta, Ankita Jha, Rashmi K. Ambasta & Pravir Kumar. (2021) Regulatory mechanism of cyclins and cyclin-dependent kinases in post-mitotic neuronal cell division. Life Sciences 285, pages 120006.
Crossref
Jianfeng Ping, Chao Zhou, Yongqiang Dong, Xudong Wu, Xiaogang Huang, Bin Sun, Bin Zeng, Fangming Xu & Wenqing Liang. (2021) Modulating immune microenvironment during bone repair using biomaterials: Focusing on the role of macrophages. Molecular Immunology 138, pages 110-120.
Crossref
Sean Harrop, Neha Mehta-Shah, Criselle Dsouza, Ella Thompson, Anand Deva & Henry Miles Prince. (2021) An Update on the Current Genomic Landscape of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Cancers 13:19, pages 4921.
Crossref
Nishtha Malhotra, Rohan Gupta & Pravir Kumar. (2021) Pharmacological relevance of CDK inhibitors in Alzheimer's disease. Neurochemistry International 148, pages 105115.
Crossref
Shiyu Wang, Qingliang Ma, Ziang Xie, Yang Shen, Bingjie Zheng, Chao Jiang, Putao Yuan, Qin An, Shunwu Fan & Zhiwei Jie. (2021) An Antioxidant Sesquiterpene Inhibits Osteoclastogenesis Via Blocking IPMK/TRAF6 and Counteracts OVX‐ Induced Osteoporosis in Mice . Journal of Bone and Mineral Research 36:9, pages 1850-1865.
Crossref
Jeevithan Elango, Bin Bao & Wenhui Wu. (2021) The hidden secrets of soluble RANKL in bone biology. Cytokine 144, pages 155559.
Crossref
Mouna Ferbebouh, Francis Vallières, Mohamed Benderdour & Julio Fernandes. (2021) The pathophysiology of immunoporosis: innovative therapeutic targets. Inflammation Research 70:8, pages 859-875.
Crossref
Xinyue Liang, Yafei Hou, Lijuan Han, Shuxiang Yu, Yunyun Zhang, Xiumei Cao & Jianshe Yan. (2021) ELMO1 Regulates RANKL-Stimulated Differentiation and Bone Resorption of Osteoclasts. Frontiers in Cell and Developmental Biology 9.
Crossref
Akito Tomomura, Kenjiro Bandow & Mineko Tomomura. (2021) Purification and Biological Function of Caldecrin. Medicines 8:8, pages 41.
Crossref
Yanben Wang, Qichang Yang, Ziyuan Fu, Peng Sun, Tan Zhang, Kelei Wang, Xinyu Li & Yu Qian. (2021) Hinokitiol inhibits RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced bone loss in vivo. International Immunopharmacology 96, pages 107619.
Crossref
Shiika Hara, Yoshie Nagai‐Yoshioka, Ryota Yamasaki, Yoshiyuki Adachi, Yuko Fujita, Kouji Watanabe, Kenshi Maki, Tatsuji Nishihara & Wataru Ariyoshi. (2020) Dectin‐1–mediated suppression of RANKL‐induced osteoclastogenesis by glucan from baker's yeast. Journal of Cellular Physiology 236:7, pages 5098-5107.
Crossref
Wen Xiao, Yanyan Wei, Fang Yang, Xiangyi Lu, Shuowen Liu, Yongling Long & Yang Yu. (2021) Cistanche deserticola polysaccharide inhibits OVX-induced bone loss in mice and RANKL-induced osteoclastogenesis. Journal of Functional Foods 81, pages 104464.
Crossref
Gyeong Do Park, Yoon-Hee Cheon, So Young Eun, Chang Hoon Lee, Myeung Su Lee, Ju-Young Kim & Hae Joong Cho. (2021) β-Boswellic Acid Inhibits RANKL-Induced Osteoclast Differentiation and Function by Attenuating NF-κB and Btk-PLCγ2 Signaling Pathways. Molecules 26:9, pages 2665.
Crossref
Xiaokang Jia, Huaichang Zhu, Gaopan Li, Mengliu Lan, Xiaoyan Li, Mingqing Huang, Wen Xu & Shuisheng Wu. (2021) Anti-osteoporotic effects of alisol C 23-acetate via osteoclastogenesis inhibition. Biomedicine & Pharmacotherapy 137, pages 111321.
Crossref
Seong Cheol Kim, Hyeon Jeong Kim, Gi Eun Park, Ramesh Prasad Pandey, Jisun Lee, Jae Kyung Sohng & Yong Il Park. (2021) Trilobatin ameliorates bone loss via suppression of osteoclast cell differentiation and bone resorptive function in vitro and in vivo. Life Sciences 270, pages 119074.
Crossref
Michèle Roy, Elizabeth Stephens, Sophie Bouhour & Sophie Roux. (2021) RabGAP TBC1D25 is involved in human osteoclast activity. European Journal of Cell Biology 100:3, pages 151145.
Crossref
Ismael Y. Karkache, Jeyaram R. Damodaran, David H.H. Molstad & Elizabeth W. Bradley. (2021) Serine/threonine phosphatases in osteoclastogenesis and bone resorption. Gene 771, pages 145362.
Crossref
Chung-Min Kang, Seunghan Mo, Mijeong Jeon, Ui-Won Jung, Yooseok Shin, Jin-Su Shin, Bo-Young Shin, Sang-Kyou Lee, Hyung-Jun Choi & Je Seon Song. (2021) Intranuclear Delivery of Nuclear Factor-Kappa B p65 in a Rat Model of Tooth Replantation. International Journal of Molecular Sciences 22:4, pages 1987.
Crossref
Zhejun Sun, Yuting Zhang, Huihao Zhou, Jun Xu & Qiong Gu. (2021) Diverse diterpenoids and sesquiterpenoids from Siegesbeckia pubescens and their activity against RANKL-induced osteoclastogenesis. Bioorganic Chemistry 107, pages 104537.
Crossref
Gaurav Swarnkar, Manoj Arra, Suresh Adapala & Yousef Abu-Amer. 2021. NF-κB Transcription Factors. NF-κB Transcription Factors 267 282 .
Xin Zhi, Qian Chen, Shaojun Song, Zhengrong Gu, Wenqiang Wei, Huiwen Chen, Xiao Chen, Weizong Weng, Qirong Zhou, Jin Cui & Liehu Cao. (2020) Myostatin Promotes Osteoclastogenesis by Regulating Ccdc50 Gene Expression and RANKL-Induced NF-κB and MAPK Pathways. Frontiers in Pharmacology 11.
Crossref
Yanting Li, Nan Li, Xiaojun Zhao, Bo Zhang, Lingling Yang, Jingjing Liu, Hunter Snooks, Changling Hu & Xueqin Ma. (2020) Beneficial effect of 2’-acetylacteoside on ovariectomized mice via modulating the function of bone resorption. Biomedicine & Pharmacotherapy 131, pages 110747.
Crossref
Isadora Akemi Uehara, Luiz Ricardo Soldi & Marcelo José Barbosa Silva. (2020) Current perspectives of osteoclastogenesis through estrogen modulated immune cell cytokines. Life Sciences 256, pages 117921.
Crossref
Ryan T. Bishop, Silvia Marino, Giovana Carrasco, Boya Li, Richard J. Allen, Anna Sparatore, Penelope D. Ottewell, Patrick Mollat, Andrew H. Sims, Mattia Capulli, Ning Wang & Aymen I. Idris. (2020) Combined administration of a small-molecule inhibitor of TRAF6 and Docetaxel reduces breast cancer skeletal metastasis and osteolysis. Cancer Letters 488, pages 27-39.
Crossref
Yi Zhao, Lingfei Jia, Yunfei Zheng & Weiran Li. (2020) Involvement of Noncoding RNAs in the Differentiation of Osteoclasts. Stem Cells International 2020, pages 1-23.
Crossref
Huiwen Chen, Chao Fang, Xin Zhi, Shaojun Song, Yanqiu Gu, Xiaofei Chen, Jin Cui, Yan Hu, Weizong Weng, Qirong Zhou, Yajun Wang, Yao Wang, Hao Jiang, Xiaoqun Li, Liehu Cao, Xiao Chen & Jiacan Su. (2020) Neobavaisoflavone inhibits osteoclastogenesis through blocking RANKL signalling‐mediated TRAF6 and c‐Src recruitment and NF‐κB, MAPK and Akt pathways. Journal of Cellular and Molecular Medicine 24:16, pages 9067-9084.
Crossref
Ming-Zhi Huang, Yong Zhuang, Xu Ning, Hao Zhang, Zhi-Min Shen & Xian-Wen Shang. (2020) Artesunate inhibits osteoclastogenesis through the miR-503/RANK axis. Bioscience Reports 40:7.
Crossref
John Nguyen, Semaj Kelly, Ryan Wood, Brian Heubel & Anja Nohe. (2020) A Synthetic Peptide, CK2.3, Inhibits RANKL-Induced Osteoclastogenesis through BMPRIa and ERK Signaling Pathway. Journal of Developmental Biology 8:3, pages 12.
Crossref
Jinwei Lu, Zhihui Kuang, Tao Chen, Chenyi Ye, Weiduo Hou, Lan Tang, Yazhou Chen & Rongxin He. (2020) Isoalantolactone inhibits RANKL-induced osteoclast formation via multiple signaling pathways. International Immunopharmacology 84, pages 106550.
Crossref
Jumpei Teramachi, Hirofumi Tenshin, Masahiro Hiasa, Asuka Oda, Ariunzaya Bat-Erdene, Takeshi Harada, Shingen Nakamura, Mohannad Ashtar, So Shimizu, Masami Iwasa, Kimiko Sogabe, Masahiro Oura, Shiro Fujii, Kumiko Kagawa, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto & Masahiro Abe. (2020) TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma. Haematologica 106:5, pages 1401-1413.
Crossref
Katarzyna Błaszczak-Świątkiewicz. (2020) New Selective Progesterone Receptor Modulators and Their Impact on the RANK/RANKL Complex Activity. Molecules 25:6, pages 1321.
Crossref
Xiang Guo, Jinyu Ji, Zhitao Feng, Xiaoqiang Hou, Yanan Luo & Zhigang Mei. (2020) A network pharmacology approach to explore the potential targets underlying the effect of sinomenine on rheumatoid arthritis. International Immunopharmacology 80, pages 106201.
Crossref
Enas A. Fouad-Elhady, Hadeer A. Aglan, Rasha E. Hassan, Hanaa H. Ahmed & Gilane M. Sabry. (2020) Modulation of bone turnover aberration: A target for management of primary osteoporosis in experimental rat model. Heliyon 6:2, pages e03341.
Crossref
Greg Hutchings, Lisa Moncrieff, Claudia Dompe, Krzysztof Janowicz, Rafał Sibiak, Artur Bryja, Maurycy Jankowski, Paul Mozdziak, Dorota Bukowska, Paweł Antosik, Jamil Shibli, Marta Dyszkiewicz-Konwińska, Małgorzata Bruska, Bartosz Kempisty & Hanna Piotrowska-Kempisty. (2020) Bone Regeneration, Reconstruction and Use of Osteogenic Cells; from Basic Knowledge, Animal Models to Clinical Trials. Journal of Clinical Medicine 9:1, pages 139.
Crossref
Victor J. F. Kitano, Yoko Ohyama, Chiyomi Hayashida, Junta Ito, Mari Okayasu, Takuya Sato, Toru Ogasawara, Maki Tsujita, Akemi Kakino, Jun Shimada, Tatsuya Sawamura & Yoshiyuki Hakeda. (2020) LDL uptake-dependent phosphatidylethanolamine translocation to the cell surface promotes fusion of osteoclast-like cells. Journal of Cell Science.
Crossref
Jiahong Meng, Wenkan Zhang, Cong Wang, Wei Zhang, Chenhe Zhou, Guangyao Jiang, Jianqiao Hong, Shigui Yan & Weiqi Yan. (2020) Catalpol suppresses osteoclastogenesis and attenuates osteoclast-derived bone resorption by modulating PTEN activity. Biochemical Pharmacology 171, pages 113715.
Crossref
Aymen I. Idris. 2020. Encyclopedia of Bone Biology. Encyclopedia of Bone Biology 294 304 .
Samantha K. Atkins, Farwah Iqbal, Johana Barrientos, Cecilia Giachelli & Elena Aikawa. 2020. Cardiovascular Calcification and Bone Mineralization. Cardiovascular Calcification and Bone Mineralization 391 419 .
Basem M. Abdallah, Enas M. Ali, Hany Elsawy, Gehan M. Badr, Ashraf M. Abdel-Moneim & Abdullah M. Alzahrani. (2019) The Coumarin Derivative 5′-Hydroxy Auraptene Suppresses Osteoclast Differentiation via Inhibiting MAPK and c-Fos/NFATc1 Pathways. BioMed Research International 2019, pages 1-10.
Crossref
Jianping Huang, Haixing Wang, Meiling Huang, Zhixian Zong, Xinyou Wu, Jianbin Xu, Huiyao Lan, Jinchang Zheng, Xiaoting Zhang, Yuk Wai Lee, Bo Wei, Liao Cui, Gang Li & Sien Lin. (2019) Asiatic Acid Attenuates Bone Loss by Regulating Osteoclastic Differentiation. Calcified Tissue International 105:5, pages 531-545.
Crossref
Jiahong Meng, Chenhe Zhou, Wenkan Zhang, Wei Wang, Bin He, Bin Hu, Guangyao Jiang, Yangxin Wang, Jianqiao Hong, Sihao Li, Jiamin He, Shigui Yan & Weiqi Yan. (2019) Stachydrine prevents LPS‐induced bone loss by inhibiting osteoclastogenesis via NF‐κB and Akt signalling. Journal of Cellular and Molecular Medicine 23:10, pages 6730-6743.
Crossref
Kangxian Zhao, Yewei Jia, Jiaxuan Peng, Cong Pang, Tan Zhang, Weiqi Han, Jiawei Jiang, Xuanyuan Lu, Jiling Zhu & Yu Qian. (2019) Anacardic acid inhibits RANKL‐induced osteoclastogenesis in vitro and prevents ovariectomy‐induced bone loss in vivo . The FASEB Journal 33:8, pages 9100-9115.
Crossref
Kun ChenPei Ying NgRuiying ChenDorothy HuShawn BerryRoland Baron & Francesca Gori. (2019) Sfrp4 repression of the Ror2/Jnk cascade in osteoclasts protects cortical bone from excessive endosteal resorption. Proceedings of the National Academy of Sciences 116:28, pages 14138-14143.
Crossref
Youqiang Sun, Yuhao Liu, Wei He, Chao Wang, Jennifer Tickner, Vincent Kuek, Chi Zhou, Haibin Wang, Xuting Zou, Zhinan Hong, Fan Yang, Min Shao, Leilei Chen & Jiake Xu. (2018) Cajaninstilbene acid inhibits osteoporosis through suppressing osteoclast formation and RANKL‐induced signaling pathways. Journal of Cellular Physiology 234:7, pages 11792-11804.
Crossref
Jeevithan Elango, Saeed Ur Rahman, Yves Henrotin, José Eduardo Maté Sánchez de Val, Bin Bao, Shujun Wang, Bailin Li & Wenhui Wu. (2019) Parathyroid Hormone-Related Protein (PTHrP) Accelerates Soluble RANKL Signals for Downregulation of Osteogenesis of Bone Mesenchymal Stem Cells. Journal of Clinical Medicine 8:6, pages 836.
Crossref
Younglim Son, Eun Mi Lee, Do Yup Lee, Jong Hun Lee & Sangtaek Oh. (2019) Longan fruit increase bone mineral density in zebrafish and ovariectomized rat by suppressing RANKL-induced osteoclast differentiation. Phytomedicine 59, pages 152910.
Crossref
Hye Jung Ihn, Taeho Lee, Doohyun Lee, Jong-Sup Bae, Sang-Hyun Kim, Il Ho Jang, Yong Chul Bae, Hong-In Shin & Eui Kyun Park. (2019) Inhibitory Effect of KP-A038 on Osteoclastogenesis and Inflammatory Bone Loss Is Associated With Downregulation of Blimp1. Frontiers in Pharmacology 10.
Crossref
Hnin Ei Thu, Zahid Hussain, Isa Naina Mohamed & Ahmad Nazrun Shuid. (2019) Eurycoma longifolia, a promising suppressor of RANKL-induced differentiation and activation of osteoclasts: An in vitro mechanistic evaluation. Journal of Ayurveda and Integrative Medicine 10:2, pages 102-110.
Crossref
Jonathan J. Morgan, Roisin M. McAvera & Lisa J. Crawford. (2019) TRAF6 Silencing Attenuates Multiple Myeloma Cell Adhesion to Bone Marrow Stromal Cells. International Journal of Molecular Sciences 20:3, pages 702.
Crossref
Bin Hu, Xuewu Sun, Yute Yang, Zhimin Ying, Jiahong Meng, Chenhe Zhou, Guangyao Jiang, Sihao Li, Fengfeng Wu, Xiang Zhao, Hanxiao Zhu, Haobo Wu, Xunzi Cai, Zhongli Shi & Shigui Yan. (2018) Tomatidine suppresses osteoclastogenesis and mitigates estrogen deficiency‐induced bone mass loss by modulating TRAF6‐mediated signaling. The FASEB Journal 33:2, pages 2574-2586.
Crossref
Xiaobin Guo, Yu Liu, Jiaxiang Bai, Binqing Yu, Menglei Xu, Houyi Sun, Jining Shen, Jiayi Lin, Hongbo Zhang, Dongqing Wang, Dechun Geng & Guoqing Pan. (2019) Efficient Inhibition of Wear-Debris-Induced Osteolysis by Surface Biomimetic Engineering of Titanium Implant with a Mussel-Derived Integrin-Targeting Peptide. Advanced Biosystems 3:2, pages 1800253.
Crossref
So Young Park, Eun Mi Choi, Kwang Sik Suh, Hyun-Sook Kim, Sang Ouk Chin, Sang Youl Rhee, Deog-Yoon Kim, Seungjoon Oh & Suk Chon. (2019) Tetrabromobisphenol A Promotes the Osteoclastogenesis of RAW264.7 Cells Induced by Receptor Activator of NF-kappa B Ligand In Vitro. Journal of Korean Medical Science 34:41.
Crossref
Kazuo Okamoto & Hiroshi Takayanagi. (2019) Osteoimmunology. Cold Spring Harbor Perspectives in Medicine 9:1, pages a031245.
Crossref
Lilian I. Plotkin & Angela Bruzzaniti. 2019. Intracellular Signalling Proteins. Intracellular Signalling Proteins 237 281 .
Eun-Jung Kim, Haesu Lee, Mi Hye Kim & Woong Mo Yang. (2018) Inhibition of RANKL-stimulated osteoclast differentiation by Schisandra chinensis through down-regulation of NFATc1 and c-fos expression. BMC Complementary and Alternative Medicine 18:1.
Crossref
Dezhi Song, Zhen Cao, Zaibing Liu, Jennifer Tickner, Heng Qiu, Chao Wang, Kai Chen, Ziyi Wang, Shiwu Dong & Jiake Xu. (2018) Cistanche deserticola polysaccharide attenuates osteoclastogenesis and bone resorption via inhibiting RANKL signaling and reactive oxygen species production . Journal of Cellular Physiology 233:12, pages 9674-9684.
Crossref
Aline Pereira, Gerly Brito, Maria Lima, Arnóbio Silva Júnior, Emanuell Silva, Adriana de Rezende, Raul Bortolin, Maria Galvan, Flávia Pirih, Raimundo Araújo Júnior, Caroline Medeiros, Gerlane Guerra & Aurigena Araújo. (2018) Metformin Hydrochloride-Loaded PLGA Nanoparticle in Periodontal Disease Experimental Model Using Diabetic Rats. International Journal of Molecular Sciences 19:11, pages 3488.
Crossref
Su-Bin Yu, Hye-Jin Kim, Hae-Mi Kang, Bong-Soo Park, Ji-Hye Lee & In-Ryoung Kim. (2018) Cordycepin Accelerates Osteoblast Mineralization and Attenuates Osteoclast Differentiation In Vitro. Evidence-Based Complementary and Alternative Medicine 2018, pages 1-10.
Crossref
Brendan F. Boyce, Jinbo Li, Lianping Xing & Zhenqiang Yao. (2018) Bone Remodeling and the Role of TRAF3 in Osteoclastic Bone Resorption. Frontiers in Immunology 9.
Crossref
Kun Wang, Shuai Li, Yong Gao, Xiaobo Feng, Wei Liu, Rongjin Luo, Yu Song, Ji Tu, Yingle Liu & Cao Yang. (2018) BCL3 regulates RANKL-induced osteoclastogenesis by interacting with TRAF6 in bone marrow-derived macrophages. Bone 114, pages 257-267.
Crossref
Michèle Roy & Sophie Roux. (2018) Rab GTPases in Osteoclastic Endomembrane Systems. BioMed Research International 2018, pages 1-15.
Crossref
Kyung-Hyun Park-Min. (2018) Mechanisms involved in normal and pathological osteoclastogenesis. Cellular and Molecular Life Sciences 75:14, pages 2519-2528.
Crossref
Takehito Ono & Tomoki Nakashima. (2018) Recent advances in osteoclast biology. Histochemistry and Cell Biology 149:4, pages 325-341.
Crossref
Chen-he Zhou, Zhong-li Shi, Jia-hong Meng, Bin Hu, Chen-chen Zhao, Yu-te Yang, Wei Yu, Ze-xin Chen, Boon Chin Heng, Virginia-Jeni Akila Parkman, Shuai Jiang, Han-xiao Zhu, Hao-bo Wu, Wei-liang Shen & Shi-gui Yan. (2018) Sophocarpine attenuates wear particle-induced implant loosening by inhibiting osteoclastogenesis and bone resorption via suppression of the NF-κB signalling pathway in a rat model . British Journal of Pharmacology 175:6, pages 859-876.
Crossref
Kaiyuan Ji, Pengqian Zhang, Junzhen Zhang, Ruiwen Fan, Yu Liu, Shanshan Yang, Shuaipeng Hu, Xuexian Liu & Changsheng Dong. (2018) MicroRNA 143-5p regulates alpaca melanocyte migration, proliferation and melanogenesis. Experimental Dermatology 27:2, pages 166-171.
Crossref
Yoko Ohyama, Junta Ito, Victor J. Kitano, Jun Shimada & Yoshiyuki Hakeda. (2018) The polymethoxy flavonoid sudachitin suppresses inflammatory bone destruction by directly inhibiting osteoclastogenesis due to reduced ROS production and MAPK activation in osteoclast precursors. PLOS ONE 13:1, pages e0191192.
Crossref
Kazuo Okamoto & Hiroshi Takayanagi. 2018. Genetics of Bone Biology and Skeletal Disease. Genetics of Bone Biology and Skeletal Disease 261 282 .
Na Kyung Lee. (2017) RANK Signaling Pathways and Key Molecules Inducing Osteoclast Differentiation. Biomedical Science Letters 23:4, pages 295-302.
Crossref
Yilei Wei, Yu Zhan, Pengfei Chen, Zhi Liu, Haohao Zhang, Dandan Liu, Jie Zhang, Min Yu, Wei Mo, Jun Zhang & Xiaoren Zhang. (2017) Heterologous expression, purification and function of the extracellular domain of human RANK. BMC Biotechnology 17:1.
Crossref
Silvia Marino, Ryan T. Bishop, John G. Logan, Patrick Mollat & Aymen I. Idris. (2017) Pharmacological evidence for the bone-autonomous contribution of the NFκB/β-catenin axis to breast cancer related osteolysis. Cancer Letters 410, pages 180-190.
Crossref
Xiao Chen, Xin Zhi, Panpan Pan, Jin Cui, Liehu Cao, Weizong Weng, Qirong Zhou, Lin Wang, Xiao Zhai, Qingiie Zhao, Honggang Hu, Biaotong Huang & Jiacan Su. (2017) Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL‐induced osteoclastogenesis. The FASEB Journal 31:11, pages 4855-4865.
Crossref
Yu-Han Meng, Wen-Jie Zhou, Li-Ping Jin, Li-Bing Liu, Kai-Kai Chang, Jie Mei, Hui Li, Jian Wang, Da-Jin Li & Ming-Qing Li. (2017) RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death & Disease 8:10, pages e3105-e3105.
Crossref
Kazuo OkamotoTomoki NakashimaMasahiro ShinoharaTakako Negishi-KogaNoriko KomatsuAsuka TerashimaShinichiro SawaTakeshi NittaHiroshi Takayanagi. (2017) Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems. Physiological Reviews 97:4, pages 1295-1349.
Crossref
Xiao Chen, Xin Zhi, Liehu Cao, Weizong Weng, Panpan Pan, Honggang Hu, Chao Liu, Qingjie Zhao, Qirong Zhou, Jin Cui & Jiacan Su. (2017) RETRACTED ARTICLE: Matrine derivate MASM uncovers a novel function for ribosomal protein S5 in osteoclastogenesis and postmenopausal osteoporosis. Cell Death & Disease 8:9, pages e3037-e3037.
Crossref
Xiao-li Zhao, Lin-feng Chen & Zhen Wang. (2017) Aesculin modulates bone metabolism by suppressing receptor activator of NF-κB ligand (RANKL)-induced osteoclastogenesis and transduction signals. Biochemical and Biophysical Research Communications 488:1, pages 15-21.
Crossref
Sam StricksonChristoph H. EmmerichEddy T. H. GohJiazhen ZhangIan R. Kelsall, Thomas MacartneyC. James HastieAxel KnebelMark PeggieFrancesco MarchesiJ. Simon C. Arthur & Philip Cohen. (2017) Roles of the TRAF6 and Pellino E3 ligases in MyD88 and RANKL signaling. Proceedings of the National Academy of Sciences 114:17.
Crossref
Ee Min Tan, Lei Li, Inthrani Raja Indran, Nicholas Chew & Eu-Leong Yong. (2017) TRAF6 Mediates Suppression of Osteoclastogenesis and Prevention of Ovariectomy-Induced Bone Loss by a Novel Prenylflavonoid. Journal of Bone and Mineral Research 32:4, pages 846-860.
Crossref
Jiangming Yu, Lizhang Xu, Ning Xie, Kai Li, Yanhai Xi, Xiling Liu, Xuebin Zheng, Xiongsheng Chen, Xiaojian Ye & Daixu Wei. (2017) Optimal Zn-Modified Ca–Si-Based Ceramic Nanocoating with Zn Ion Release for Osteoblast Promotion and Osteoclast Inhibition in Bone Tissue Engineering. Journal of Nanomaterials 2017, pages 1-9.
Crossref
Renu Sharma, Dhiraj Kumar, Niraj Kumar Jha, Saurabh Kumar Jha, Rashmi K Ambasta & Pravir Kumar. (2017) Re-expression of cell cycle markers in aged neurons and muscles: Whether cells should divide or die?. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1863:1, pages 324-336.
Crossref
Michelle Fennen, Thomas Pap & Berno Dankbar. (2016) Smad-dependent mechanisms of inflammatory bone destruction. Arthritis Research & Therapy 18:1.
Crossref
Megumi Funakoshi-Tago, Kentaro Ohsawa, Toshiyuki Ishikawa, Fumika Nakamura, Fumihito Ueda, Yuji Narukawa, Fumiyuki Kiuchi, Hiroomi Tamura, Kenji Tago & Tadashi Kasahara. (2016) Inhibitory effects of flavonoids extracted from Nepalese propolis on the LPS signaling pathway. International Immunopharmacology 40, pages 550-560.
Crossref
Amanda L. Rinkenbaugh, Patricia C. Cogswell, Barbara Calamini, Denise E. Dunn, Anders I. Persson, William A. Weiss, Donald C. Lo & Albert S. Baldwin. (2016) IKK/NF-κB signaling contributes to glioblastoma stem cell maintenance. Oncotarget 7:43, pages 69173-69187.
Crossref
Toshifumi Fujiwara, Shiqiao Ye, Thiago Castro-Gomes, Caylin G. Winchell, Norma W. Andrews, Daniel E. Voth, Kottayil I. Varughese, Samuel G. Mackintosh, Yunfeng Feng, Nathan Pavlos, Takashi Nakamura, Stavros C. Manolagas & Haibo Zhao. (2016) PLEKHM1/DEF8/RAB7 complex regulates lysosome positioning and bone homeostasis. JCI Insight 1:17.
Crossref
Chaoqun Yang, Peipei Ding, Qingkai Wang, Long Zhang, Xin Zhang, Jianquan Zhao, Enjie Xu, Na Wang, Jianfeng Chen, Guang Yang, Weiguo Hu & Xuhui Zhou. (2016) Inhibition of Complement Retards Ankylosing Spondylitis Progression. Scientific Reports 6:1.
Crossref
Sandra Segeletz & Bernard Hoflack. (2016) Proteomic approaches to study osteoclast biology. PROTEOMICS 16:19, pages 2545-2556.
Crossref
Jiyeon Yu, Hyeongseok Yun, Bongjin Shin, Yongjin Kim, Eui-Soon Park, Seunga Choi, Jungeun Yu, Dulshara Sachini Amarasekara, Sumi Kim, Jun-ichiro Inoue, Matthew C. Walsh, Yongwon Choi, Masamichi Takami & Jaerang Rho. (2016) Interaction of Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) and Vav3 in the Receptor Activator of Nuclear Factor κB (RANK) Signaling Complex Enhances Osteoclastogenesis. Journal of Biological Chemistry 291:39, pages 20643-20660.
Crossref
Eva González-Suárez & Adrián Sanz-Moreno. (2016) RANK as a therapeutic target in cancer. The FEBS Journal 283:11, pages 2018-2033.
Crossref
Xin Wang, Ting Zheng, Ju-Hee Kang, Hua Li, Hyewon Cho, Raok Jeon, Jae-Ha Ryu & Mijung Yim. (2016) Decursin from Angelica gigas suppresses RANKL-induced osteoclast formation and bone loss. European Journal of Pharmacology 774, pages 34-42.
Crossref
Jung Ha KimNacksung Kim. (2016) Signaling Pathways in Osteoclast Differentiation. Chonnam Medical Journal 52:1, pages 12.
Crossref
Ju-Hee KangHyojung LimJi-Eun JeongMijung Yim. (2016) Attenuation of RANKL-induced Osteoclast Formation via p38-mediated NFATc1 Signaling Pathways by Extract of Euphorbia Lathyris L . Journal of Bone Metabolism 23:4, pages 207.
Crossref
Yongwon Choi, Roberta Faccio, Steven L. Teitelbaum & Hiroshi Takayanagi. 2016. Osteoimmunology. Osteoimmunology 41 70 .
Gail A. Bishop, Laura L. Stunz & Bruce S. Hostager. 2016. Encyclopedia of Immunobiology. Encyclopedia of Immunobiology 115 123 .
YINGXIAO FU, JIANHONG GU, YI WANG, YAN YUAN, XUEZHONG LIU, JIANCHUN BIAN & ZONGPING LIU. (2015) Involvement of the mitogen-activated protein kinase signaling pathway in osteoprotegerin-induced inhibition of osteoclast differentiation and maturation. Molecular Medicine Reports 12:5, pages 6939-6945.
Crossref
Eriko Sumiya, Takako Negishi-Koga, Yusuke Nagai, Ayako Suematsu, Tomomi Suda, Masahiro Shinohara, Kojiro Sato, Hideki Sanjo, Shizuo Akira & Hiroshi Takayanagi. (2015) Phosphoproteomic analysis of kinase-deficient mice reveals multiple TAK1 targets in osteoclast differentiation. Biochemical and Biophysical Research Communications 463:4, pages 1284-1290.
Crossref
Mineko Tomomura, Ryuichiro Suzuki, Yoshiaki Shirataki, Hiroshi Sakagami, Nobuaki Tamura & Akito Tomomura. (2015) Rhinacanthin C Inhibits Osteoclast Differentiation and Bone Resorption: Roles of TRAF6/TAK1/MAPKs/NF-κB/NFATc1 Signaling. PLOS ONE 10:6, pages e0130174.
Crossref
Jingjing LinDaekee LeeYongwon ChoiSoo Young Lee. (2015) The scaffold protein RACK1 mediates the RANKL-dependent activation of p38 MAPK in osteoclast precursors. Science Signaling 8:379.
Crossref
Hao Xu, Tao Xu, Xiaqing Ma & Wei Jiang. (2015) Involvement of neuronal TGF-β activated kinase 1 in the development of tolerance to morphine-induced antinociception in rat spinal cord. British Journal of Pharmacology 172:11, pages 2892-2904.
Crossref
Mai Nakayachi, Junta Ito, Chiyomi Hayashida, Yoko Ohyama, Akemi Kakino, Mari Okayasu, Takuya Sato, Toru Ogasawara, Toshio Kaneda, Naoto Suda, Tatsuya Sawamura & Yoshiyuki Hakeda. (2015) Lectin-like oxidized low-density lipoprotein receptor-1 abrogation causes resistance to inflammatory bone destruction in mice, despite promoting osteoclastogenesis in the steady state. Bone 75, pages 170-182.
Crossref
Pavithra K. Balasubramanian, Anand Balupuri, Changdev G. Gadhe & Seung Joo Cho. (2014) 3D QSAR modeling study on 7-aminofuro [2,3-c] pyridine derivatives as TAK1 inhibitors using CoMFA and COMSIA. Medicinal Chemistry Research 24:6, pages 2347-2365.
Crossref
Hiroyasu Kiyomiya, Wataru Ariyoshi, Toshinori Okinaga, Takeshi Kaneuji, Sho Mitsugi, Takuma Sakurai, Manabu Habu, Izumi Yoshioka, Kazuhiro Tominaga & Tatsuji Nishihara. (2015) IL-33 inhibits RANKL-induced osteoclast formation through the regulation of Blimp-1 and IRF-8 expression. Biochemical and Biophysical Research Communications 460:2, pages 320-326.
Crossref
Chider Chen, Kentaro Akiyama, Dandan Wang, Xingtian Xu, Bei Li, Alireza Moshaverinia, Frank Brombacher, Lingyun Sun & Songtao Shi. (2015) mTOR inhibition rescues osteopenia in mice with systemic sclerosis. Journal of Experimental Medicine 212:1, pages 73-91.
Crossref
Gaurav Swarnkar, Kannan Karuppaiah, Gabriel Mbalaviele, Tim (Hung-Po) Chen & Yousef Abu-Amer. (2014) Osteopetrosis in TAK1-deficient mice owing to defective NF-κB and NOTCH signaling. Proceedings of the National Academy of Sciences 112:1, pages 154-159.
Crossref
Sae Mi Wi, Gyuyoung Moon, Juhong Kim, Seong-Tae Kim, Jae-Hyuck Shim, Eunyoung Chun & Ki-Young Lee. (2014) TAK1-ECSIT-TRAF6 Complex Plays a Key Role in the TLR4 Signal to Activate NF-κB. Journal of Biological Chemistry 289:51, pages 35205-35214.
Crossref
Yeon-Ho Chung, Youngsaeng Jang, Bongkun Choi, Da-Hyun Song, Eun-Jin Lee, Sang-Min Kim, Youngsup Song, Sang-Wook Kang, Seung-Yong Yoon & Eun-Ju Chang. (2014) Beclin-1 Is Required for RANKL-Induced Osteoclast Differentiation. Journal of Cellular Physiology 229:12, pages 1963-1971.
Crossref
Matthew C. Walsh & Yongwon Choi. (2014) Biology of the RANKL–RANK–OPG System in Immunity, Bone, and Beyond. Frontiers in Immunology 5.
Crossref
Bo Yu, Jia Chang, Yunsong Liu, Jiong Li, Kareena Kevork, Khalid Al-Hezaimi, Dana T Graves, No-Hee Park & Cun-Yu Wang. (2014) Wnt4 signaling prevents skeletal aging and inflammation by inhibiting nuclear factor-κB. Nature Medicine 20:9, pages 1009-1017.
Crossref
Jong Baek, Ju-Young Kim, Yoon-Hee Cheon, Sun-Hyang Park, Sung-Jun Ahn, Kwon-Ha Yoon, Jaemin Oh & Myeung Lee. (2014) Aconitum pseudo-laeve var. erectum Inhibits Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Osteoclastogenesis via the c-Fos/nuclear Factor of Activated T-Cells, Cytoplasmic 1 Signaling Pathway and Prevents Lipopolysaccharide-Induced Bone Loss in Mice. Molecules 19:8, pages 11628-11644.
Crossref
Ju-Young Kim, Yoon-Hee Cheon, Sung Chul Kwak, Jong Min Baek, Kwon-Ha Yoon, Myeung Su Lee & Jaemin Oh. (2014) Emodin Regulates Bone Remodeling by Inhibiting Osteoclastogenesis and Stimulating Osteoblast Formation. Journal of Bone and Mineral Research 29:7, pages 1541-1553.
Crossref
Wen-Fei Chiou, Yu-Ling Huang & Yen-Wenn Liu. (2014) (+)-Vitisin A Inhibits Osteoclast Differentiation by Preventing TRAF6 Ubiquitination and TRAF6-TAK1 Formation to Suppress NFATc1 Activation. PLoS ONE 9:2, pages e89159.
Crossref
Z J Zhai, H W Li, G W Liu, X H Qu, B Tian, W Yan, Z Lin, T T Tang, A Qin & K R Dai. (2014) Andrographolide suppresses RANKL ‐induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo . British Journal of Pharmacology 171:3, pages 663-675.
Crossref
Aaron Broege, Lan Pham, Eric D. Jensen, Ann Emery, Tsang-Hai Huang, Melissa Stemig, Hideyuki Beppu, Anna Petryk, Michael O'Connor, Kim Mansky & Raj Gopalakrishnan. (2013) Bone Morphogenetic Proteins Signal Via SMAD and Mitogen-activated Protein (MAP) Kinase Pathways at Distinct Times during Osteoclastogenesis. Journal of Biological Chemistry 288:52, pages 37230-37240.
Crossref
Sagar Deshpande, Aaron W. James, Jordan Blough, Alexis Donneys, Stewart C. Wang, Paul S. Cederna, Steven R. Buchman & Benjamin Levi. (2013) Reconciling the effects of inflammatory cytokines on mesenchymal cell osteogenic differentiation. Journal of Surgical Research 185:1, pages 278-285.
Crossref
Sarah L. ReaJohn P. WalshRobert LayfieldThomas RatajczakJiake Xu. (2013) New Insights Into the Role of Sequestosome 1/p62 Mutant Proteins in the Pathogenesis of Paget's Disease of Bone. Endocrine Reviews 34:4, pages 501-524.
Crossref
Feng Xu & Steven L. Teitelbaum. (2013) Osteoclasts: New Insights. Bone Research 1:1, pages 11-26.
Crossref
Zhi-feng Wei, Bei Tong, Yu-feng Xia, Qian Lu, Gui-xin Chou, Zheng-tao Wang & Yue Dai. (2013) Norisoboldine Suppresses Osteoclast Differentiation through Preventing the Accumulation of TRAF6-TAK1 Complexes and Activation of MAPKs/NF-κB/c-Fos/NFATc1 Pathways. PLoS ONE 8:3, pages e59171.
Crossref
Antonella Galeone, Domenico Paparella, Silvia Colucci, Maria Grano & Giacomina Brunetti. (2013) The Role of TNF- α and TNF Superfamily Members in the Pathogenesis of Calcific Aortic Valvular Disease . The Scientific World Journal 2013, pages 1-10.
Crossref
Sara Gorjestani, Bryant G. Darnay & Xin Lin. (2012) Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) and TGFβ-activated Kinase 1 (TAK1) Play Essential Roles in the C-type Lectin Receptor Signaling in Response to Candida albicans Infection. Journal of Biological Chemistry 287:53, pages 44143-44150.
Crossref
Wei Gong, Huan Dou, Xianqin Liu, Lingyun Sun & Yayi Hou. (2012) Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor- κ B ligand-induced osteoclastogenesis . Clinical and Experimental Pharmacology and Physiology 39:10, pages 886-893.
Crossref
Yuu Taguchi, Yoko Kiga, Jin Gohda & Jun-ichiro Inoue. (2012) Identification and characterization of anti-osteoclastogenic peptides derived from the cytoplasmic tail of receptor activator of nuclear factor kappa B. Journal of Bone and Mineral Metabolism 30:5, pages 543-553.
Crossref
Mari Okayasu, Mai Nakayachi, Chiyomi Hayashida, Junta Ito, Toshio Kaneda, Masaaki Masuhara, Naoto Suda, Takuya Sato & Yoshiyuki Hakeda. (2012) Low-density Lipoprotein Receptor Deficiency Causes Impaired Osteoclastogenesis and Increased Bone Mass in Mice because of Defect in Osteoclastic Cell-Cell Fusion. Journal of Biological Chemistry 287:23, pages 19229-19241.
Crossref
W. He & B. N. Cronstein. (2012) Adenosine A1 receptor regulates osteoclast formation by altering TRAF6/TAK1 signaling. Purinergic Signalling 8:2, pages 327-337.
Crossref
Xiao-Shuang WangJia-Nan GongJia YuFang WangXin-Hua Zhang, Xiao-Lin Yin, Zhen-Qing Tan, Zi-Mian Luo, Gui-Hua YangChao ShenJun-Wu Zhang. (2012) MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia. Blood 119:21, pages 4992-5004.
Crossref
Pui Yan Jenny Chung & Wim Van Hul. (2012) Paget's Disease of Bone: Evidence for Complex Pathogenetic Interactions. Seminars in Arthritis and Rheumatism 41:5, pages 619-641.
Crossref
Xiaojuan He, Jun Shu, Li Xu, Cheng Lu & Aiping Lu. (2012) Inhibitory Effect of Astragalus Polysaccharides on Lipopolysaccharide-Induced TNF-a and IL-1β Production in THP-1 Cells. Molecules 17:3, pages 3155-3164.
Crossref
Stephen McManus & Sophie Roux. (2012) The adaptor protein p62/SQSTM1 in osteoclast signaling pathways. Journal of Molecular Signaling 7, pages 1.
Crossref
Naoto Hada, Mari Okayasu, Junta Ito, Mai Nakayachi, Chiyomi Hayashida, Toshio Kaneda, Noritaka Uchida, Takamichi Muramatsu, Chihiro Koike, Masaaki Masuhara, Takuya Sato & Yoshiyuki Hakeda. (2012) Receptor activator of NF-κB ligand-dependent expression of caveolin-1 in osteoclast precursors, and high dependency of osteoclastogenesis on exogenous lipoprotein. Bone 50:1, pages 226-236.
Crossref
Patricia Collin-Osdoby & Philip Osdoby. 2012. Bone Research Protocols. Bone Research Protocols 187 202 .
Alexander Wolf, Knut Beuerlein, Christoph Eckart, Hendrik Weiser, Beate Dickkopf, Helmut Müller, Hiroaki Sakurai & Michael Kracht. (2011) Identification and Functional Characterization of Novel Phosphorylation Sites in TAK1-Binding Protein (TAB) 1. PLoS ONE 6:12, pages e29256.
Crossref
Tetsuro Yasui, Jun Hirose, Shuichi Tsutsumi, Kozo Nakamura, Hiroyuki Aburatani & Sakae Tanaka. (2011) Epigenetic regulation of osteoclast differentiation: Possible involvement of Jmjd3 in the histone demethylation of Nfatc1. Journal of Bone and Mineral Research 26:11, pages 2665-2671.
Crossref
Alfiya Safina, Paula Sotomayor, Michelle Limoge, Carl Morrison & Andrei V. Bakin. (2011) TAK1–TAB2 Signaling Contributes to Bone Destruction by Breast Carcinoma Cells. Molecular Cancer Research 9:8, pages 1042-1053.
Crossref
R. Raju, L. Balakrishnan, V. Nanjappa, M. Bhattacharjee, D. Getnet, B. Muthusamy, J. Kurian Thomas, J. Sharma, B. A. Rahiman, H. C. Harsha, S. Shankar, T. S. K. Prasad, S. S. Mohan, G. D. Bader, M. R. Wani & A. Pandey. (2011) A comprehensive manually curated reaction map of RANKL/RANK-signaling pathway. Database 2011:0, pages bar021-bar021.
Crossref
Tetsuro Yasui, Yuho Kadono, Masaki Nakamura, Yasushi Oshima, Takumi Matsumoto, Hironari Masuda, Jun Hirose, Yasunori Omata, Hisataka Yasuda, Takeshi Imamura, Kozo Nakamura & Sakae Tanaka. (2011) Regulation of RANKL-induced osteoclastogenesis by TGF-β through molecular interaction between Smad3 and Traf6. Journal of Bone and Mineral Research 26:7, pages 1447-1456.
Crossref
Takeshi Kaneuji, Wataru Ariyoshi, Toshinori Okinaga, Akihiro Toshinaga, Tetsu Takahashi & Tatsuji Nishihara. (2011) Mechanisms involved in regulation of osteoclastic differentiation by mechanical stress-loaded osteoblasts. Biochemical and Biophysical Research Communications 408:1, pages 103-109.
Crossref
Kazuya Hirata & Takahisa Sugita. (2011) Involvements of mitogen-activated protein kinase cascades in osteoclastogenesis. Inflammation and Regeneration 31:5, pages 425-430.
Crossref
F. Patrick Ross. 2011. Vitamin D. Vitamin D 335 347 .
Roberta Faccio, Yongwon Choi, Steven L. Teitelbaum & Hiroshi Takayanagi. 2011. Osteoimmunology. Osteoimmunology 141 185 .
J. C. Crockett, D. J. Mellis, D. I. Scott & M. H. Helfrich. (2010) New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis. Osteoporosis International 22:1, pages 1-20.
Crossref
Kabsun Kim, Jung Ha Kim, Bang Ung Youn, Hye Mi Jin & Nacksung Kim. (2010) Pim-1 Regulates RANKL-Induced Osteoclastogenesis via NF-κB Activation and NFATc1 Induction. The Journal of Immunology 185:12, pages 7460-7466.
Crossref
Andrzej Plewka, Paweł Madej, Danuta Plewka, Grażyna Nowaczyk, Michał Morek, Edyta Bogunia, Monika Ciupińska-Kajor & Karolina Sieroń-Stołtny. (2010) The TRAF2 and TRAF6 expression in myomas and myometrium of women in reproduction and perimenopausal age.. Folia Histochemica et Cytobiologica 48:3.
Crossref
Young-Sun Lee, Yang-Soon Kim, Sun-Young Lee, Geun-Hyang Kim, Beom-Jun Kim, Seung-Hun Lee, Ki-Up Lee, Ghi-Su Kim, Seung-Whan Kim & Jung-Min Koh. (2010) AMP kinase acts as a negative regulator of RANKL in the differentiation of osteoclasts. Bone 47:5, pages 926-937.
Crossref
WF Chiou, JF Liao, CY Huang & CC Chen. (2010) 2-Methoxystypandrone represses RANKL-mediated osteoclastogenesis by down-regulating formation of TRAF6-TAK1 signalling complexes. British Journal of Pharmacology 161:2, pages 321-335.
Crossref
Hisaaki Shinohara & Tomohiro Kurosaki. (2009) Comprehending the complex connection between PKCβ, TAK1, and IKK in BCR signaling. Immunological Reviews 232:1, pages 300-318.
Crossref
Sung Il Kim, Joon Hyeok Kwak, Hee-Jun Na, Jin Kuk Kim, Yan Ding & Mary E. Choi. (2009) Transforming Growth Factor-β (TGF-β1) Activates TAK1 via TAB1-mediated Autophosphorylation, Independent of TGF-β Receptor Kinase Activity in Mesangial Cells. Journal of Biological Chemistry 284:33, pages 22285-22296.
Crossref
Reinhard Kodym, Elisabeth Kodym & Michael D. Story. (2009) Short double-stranded RNAs of specific sequence activate ribosomal TAK1-D and induce a global inhibition of translation. Biological Chemistry 390:5-6, pages 453-462.
Crossref
Lisa J. Robinson, Beatrice B. Yaroslavskiy, Reed D. Griswold, Eva V. Zadorozny, Lida Guo, Irina L. Tourkova & Harry C. Blair. (2009) Estrogen inhibits RANKL-stimulated osteoclastic differentiation of human monocytes through estrogen and RANKL-regulated interaction of estrogen receptor-α with BCAR1 and Traf6. Experimental Cell Research 315:7, pages 1287-1301.
Crossref
Mukesh Kumar, Denys Y. Makonchuk, Hong Li, Ashwani Mittal & Ashok Kumar. (2009) TNF-Like Weak Inducer of Apoptosis (TWEAK) Activates Proinflammatory Signaling Pathways and Gene Expression through the Activation of TGF-β-Activated Kinase 1. The Journal of Immunology 182:4, pages 2439-2448.
Crossref
Huang Hongming & Hou Jian. (2009) Bortezomib inhibits maturation and function of osteoclasts from PBMCs of patients with multiple myeloma by downregulating TRAF6. Leukemia Research 33:1, pages 115-122.
Crossref
Aymen I. Idris, Stuart H. Ralston & Rob J. van't Hof. (2009) The nitrosylated flurbiprofen derivative HCT1026 inhibits cytokine-induced signalling through a novel mechanism of action. European Journal of Pharmacology 602:2-3, pages 215-222.
Crossref
Tao Cheng, Xiao-Chun Peng, Feng-Feng Li, Xian-Long Zhang, Kong-Zu Hu, Jun-Feng Zhu & Bing-Fang Zeng. (2009) Transforming growth factor-β activated kinase 1 signaling pathways regulate TNF-α production by titanium alloy particles in RAW 264.7 cells. Journal of Biomedical Materials Research Part A, pages n/a-n/a.
Crossref
Lijian Hui, Kurt Zatloukal, Harald Scheuch, Ewa Stepniak & Erwin F. Wagner. (2008) Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. Journal of Clinical Investigation 118:12, pages 3943-3953.
Crossref
Allan R. Brasier. 2008. Cellular Signaling and Innate Immune Responses to RNA Virus Infections. Cellular Signaling and Innate Immune Responses to RNA Virus Infections 119 135 .
Yu-Chih Lo, Upendra Maddineni, Jee Y. Chung, Rebecca L. Rich, David G. Myszka & Hao Wu. (2008) High-Affinity Interaction between IKKβ and NEMO. Biochemistry 47:10, pages 3109-3116.
Crossref
Patrícia P. Saraiva, Silvania S. Teixeira, Célia Regina Nogueira & Carlos Roberto Padovani. (2008) Triiodothyronine (T3) does not induce Rankl expression in rat Ros 17/2.8 cells. Arquivos Brasileiros de Endocrinologia & Metabologia 52:1, pages 109-113.
Crossref
Su-Chang Lin, Jee Y. Chung, Betty Lamothe, Kanagalaghatta Rajashankar, Miao Lu, Yu-Chih Lo, Amy Y. Lam, Bryant G. Darnay & Hao Wu. (2008) Molecular Basis for the Unique Deubiquitinating Activity of the NF-κB Inhibitor A20. Journal of Molecular Biology 376:2, pages 526-540.
Crossref
Hiroshi Takayanagi. 2008. Principles of Bone Biology. Principles of Bone Biology 211 219 .
Teruhito Yamashita, Zhenqiang Yao, Fang Li, Qian Zhang, I. Raul Badell, Edward M. Schwarz, Sunao Takeshita, Erwin F. Wagner, Masaki Noda, Koichi Matsuo, Lianping Xing & Brendan F. Boyce. (2007) NF-κB p50 and p52 Regulate Receptor Activator of NF-κB Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc1. Journal of Biological Chemistry 282:25, pages 18245-18253.
Crossref
C. Orelio & E. Dzierzak. (2007) Expression analysis of the TAB2 protein in adult mouse tissues. Inflammation Research 56:3.
Crossref
Arnaud Besse, Betty Lamothe, Alejandro D. Campos, William K. Webster, Upendra Maddineni, Su-Chang Lin, Hao Wu & Bryant G. Darnay. (2007) TAK1-dependent Signaling Requires Functional Interaction with TAB2/TAB3. Journal of Biological Chemistry 282:6, pages 3918-3928.
Crossref
Masataka Asagiri & Hiroshi Takayanagi. (2007) The molecular understanding of osteoclast differentiation. Bone 40:2, pages 251-264.
Crossref
Bryant G. Darnay, Arnaud Besse, Ann T. Poblenz, Betty Lamothe & Jürg J. Jacoby. 2007. TNF Receptor Associated Factors (TRAFs). TNF Receptor Associated Factors (TRAFs) 152 159 .
Juan M. Zapata, Vanesa Martínez-García & Sophie Lefebvre. 2007. TNF Receptor Associated Factors (TRAFs). TNF Receptor Associated Factors (TRAFs) 1 24 .
Donald J. Davidson, Andrew J. Currie, Dawn M. E. Bowdish, Kelly L. Brown, Carrie M. Rosenberger, Rebecca C. Ma, Johan Bylund, Paul A. Campsall, Anne Puel, Capucine Picard, Jean-Laurent Casanova, Stuart E. Turvey, Robert E. W. Hancock, Rebecca S. Devon & David P. Speert. (2006) IRAK-4 Mutation (Q293X): Rapid Detection and Characterization of Defective Post-Transcriptional TLR/IL-1R Responses in Human Myeloid and Non-Myeloid Cells . The Journal of Immunology 177:11, pages 8202-8211.
Crossref
Min-Kyung Choo, Noritaka Kawasaki, Pattama Singhirunnusorn, Keiichi Koizumi, Shintaro Sato, Shizuo Akira, Ikuo Saiki & Hiroaki Sakurai. (2006) Blockade of transforming growth factor-β-activated kinase 1 activity enhances TRAIL-induced apoptosis through activation of a caspase cascade. Molecular Cancer Therapeutics 5:12, pages 2970-2976.
Crossref
H Huang, J Ryu, J Ha, E-J Chang, H J Kim, H-M Kim, T Kitamura, Z H Lee & H-H Kim. (2006) Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-κB transactivation by RANKL. Cell Death & Differentiation 13:11, pages 1879-1891.
Crossref
Ayako Mochizuki, Masamichi Takami, Tadaharu Kawawa, Reina Suzumoto, Takahisa Sasaki, Akihiko Shiba, Hiroaki Tsukasaki, Baohong Zhao, Rika Yasuhara, Tetsuo Suzawa, Yoichi Miyamoto, Yongwon Choi & Ryutaro Kamijo. (2006) Identification and Characterization of the Precursors Committed to Osteoclasts Induced by TNF-Related Activation-Induced Cytokine/Receptor Activator of NF-κB Ligand. The Journal of Immunology 177:7, pages 4360-4368.
Crossref
Xu Feng. (2006) RANK signaling pathways as potent and specific therapeutic targets for bone erosion in rheumatoid arthritis. Future Rheumatology 1:5, pages 567-578.
Crossref
Taosheng ChenXu Feng. (2006) Cell-Based Assay Strategy for Identification of Motif-Specific RANK Signaling Pathway Inhibitors. ASSAY and Drug Development Technologies 4:4, pages 473-482.
Crossref
V Bottero, S Withoff & I M Verma. (2006) NF-κB and the regulation of hematopoiesis. Cell Death & Differentiation 13:5, pages 785-797.
Crossref
Noriyuki Uemura, Taisuke Kajino, Hideki Sanjo, Shintaro Sato, Shizuo Akira, Kunihiro Matsumoto & Jun Ninomiya-Tsuji. (2006) TAK1 Is a Component of the Epstein-Barr Virus LMP1 Complex and Is Essential for Activation of JNK but Not of NF-κB. Journal of Biological Chemistry 281:12, pages 7863-7872.
Crossref
Aurore Morlon, Asma Smahi & Arnold Munnich. (2006) De nouveaux gènes candidates pour les dysplasies ectodermiques anhidrotiques : TAB2 , TRAF6 et TAK1 . médecine/sciences 22:3, pages 229-230.
Crossref
Andreas R. Klatt, Gabriele Klinger, Olga Neumüller, Bernd Eidenmüller, Ingrid Wagner, Tatjana Achenbach, Thomas Aigner & Eckart Bartnik. (2006) TAK1 downregulation reduces IL-1β induced expression of MMP13, MMP1 and TNF-alpha. Biomedicine & Pharmacotherapy 60:2, pages 55-61.
Crossref
Teiji Wada, Tomoki Nakashima, Nishina Hiroshi & Josef M Penninger. (2006) RANKL–RANK signaling in osteoclastogenesis and bone disease. Trends in Molecular Medicine 12:1, pages 17-25.
Crossref
Na Kyung Lee, Han Kyung Choi, Dong-Ku Kim & Soo Young Lee. (2006) Rac1 GTPase regulates osteoclast differentiation through TRANCE-induced NF-κB activation. Molecular and Cellular Biochemistry 281:1-2, pages 55-61.
Crossref
Rudolf Haase, Kathleen Richter, Gudrun Pfaffinger, Gilles Courtois & Klaus Ruckdeschel. (2005) Yersinia Outer Protein P Suppresses TGF-β-Activated Kinase-1 Activity to Impair Innate Immune Signaling in Yersinia enterocolitica -Infected Cells . The Journal of Immunology 175:12, pages 8209-8217.
Crossref
Kieron Brown, Sarah C.M. Vial, Neesha Dedi, Joanna M. Long, Nicholas J. Dunster & Graham M.T. Cheetham. (2005) Structural Basis for the Interaction of TAK1 Kinase with its Activating Protein TAB1. Journal of Molecular Biology 354:5, pages 1013-1020.
Crossref
Axel Thiefes, Sabine Wolter, J. Frederic Mushinski, Elke Hoffmann, Oliver Dittrich-Breiholz, Nadine Graue, Anneke Dörrie, Heike Schneider, Dagmar Wirth, Bruno Luckow, Klaus Resch & Michael Kracht. (2005) Simultaneous Blockade of NFκB, JNK, and p38 MAPK by a Kinase-inactive Mutant of the Protein Kinase TAK1 Sensitizes Cells to Apoptosis and Affects a Distinct Spectrum of Tumor Necrosis Target Genes. Journal of Biological Chemistry 280:30, pages 27728-27741.
Crossref
Xu Feng. (2005) RANKing Intracellular Signaling in Osteoclasts. IUBMB Life (International Union of Biochemistry and Molecular Biology: Life) 57:6, pages 389-395.
Crossref
Hiroshi Takatsuna, Masataka Asagiri, Takeshi Kubota, Kotaro Oka, Toshihiro Osada, Chie Sugiyama, Hiroaki Saito, Kazuhiro Aoki, Keiichi Ohya, Hiroshi Takayanagi & Kazuo Umezawa. (2004) Inhibition of RANKL-Induced Osteoclastogenesis by (−)-DHMEQ, a Novel NF-κB Inhibitor, Through Downregulation of NFATc1. Journal of Bone and Mineral Research 20:4, pages 653-662.
Crossref

Displaying 200 of 228 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.